Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25.
第一作者:
B,Fisher
第一单位:
National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212-5234, USA. bernard.fisher@nsabp.org
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);环磷酰胺(Cyclophosphamide);无病生存(Disease-Free Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);多柔比星(Doxorubicin);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);寿命表(Life Tables);乳房切除术, 根治性(Mastectomy, Radical);中年人(Middle Aged);治疗失败(Treatment Failure)
DOI
10.1200/JCO.1999.17.11.3374
PMID
10550131
发布时间
2017-02-10
- 浏览50

Journal of clinical oncology
3374-88页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文